Gynecomastia laboratory findings: Difference between revisions

	Gynecomastia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gynecomastia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gynecomastia laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gynecomastia laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gynecomastia laboratory findings
CDC on Gynecomastia laboratory findings
Gynecomastia laboratory findings in the news
Blogs on Gynecomastia laboratory findings
Directions to Hospitals Treating Gynecomastia
Risk calculators and risk factors for Gynecomastia laboratory findings

Revision as of 15:50, 2 August 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
[Test] is usually normal among patients with [disease name].
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

OR

OR

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
[Test] is usually normal among patients with [disease name].
Laboratory findings consistent with the diagnosis of [disease name] include
- [abnormal test 1]
- [abnormal test 2]
- [abnormal test 3]

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Gynecomastia}}
-{{CMG}}
+{{CMG}}; {{AE}}
-Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
+==Overview==
+*An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
+*Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
+*[Test] is usually normal among patients with [disease name].
+*Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
+OR
+*There are no diagnostic laboratory findings associated with [disease name].
+==Laboratory Findings==
+*There are no diagnostic laboratory findings associated with [disease name].
+OR
+*An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
+*[Test] is usually normal among patients with [disease name].
+*Laboratory findings consistent with the diagnosis of [disease name] include
+**[abnormal test 1]
+**[abnormal test 2]
+**[abnormal test 3]
+*Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
-==Overview==
 ==Laboratory Findings==
 * [[Human chorionic gonadotropin]] ([[HCG]])